- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
According to our latest study, the global PD-L1 Biomarker Testing market size was valued at USD 1513.1 million in 2022 and is forecast to a readjusted size of USD 4101.9 million by 2029 with a CAGR of 15.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
This report is a detailed and comprehensive analysis for global PD-L1 Biomarker Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-L1 Biomarker Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global PD-L1 Biomarker Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global PD-L1 Biomarker Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global PD-L1 Biomarker Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-L1 Biomarker Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PD-L1 Biomarker Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Eli Lilly, AstraZeneca, Roche and Bristol-Myers Squibb, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
PD-L1 Biomarker Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PD-L1 IHC 22C3 Assay
PD-L1 IHC 28-8 Assay
PD-L1 (SP142) Assay
PD-L1 (SP263) Assay
Market segment by Application
Hospital
Diagnostic Center
Others
Market segment by players, this report covers
Agilent Technologies
Eli Lilly
AstraZeneca
Roche
Bristol-Myers Squibb
Merck
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PD-L1 Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PD-L1 Biomarker Testing, with revenue, gross margin and global market share of PD-L1 Biomarker Testing from 2018 to 2023.
Chapter 3, the PD-L1 Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and PD-L1 Biomarker Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-L1 Biomarker Testing.
Chapter 13, to describe PD-L1 Biomarker Testing research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of PD-L1 Biomarker Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of PD-L1 Biomarker Testing by Type
1.3.1 Overview: Global PD-L1 Biomarker Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2022
1.3.3 PD-L1 IHC 22C3 Assay
1.3.4 PD-L1 IHC 28-8 Assay
1.3.5 PD-L1 (SP142) Assay
1.3.6 PD-L1 (SP263) Assay
1.4 Global PD-L1 Biomarker Testing Market by Application
1.4.1 Overview: Global PD-L1 Biomarker Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Others
1.5 Global PD-L1 Biomarker Testing Market Size & Forecast
1.6 Global PD-L1 Biomarker Testing Market Size and Forecast by Region
1.6.1 Global PD-L1 Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global PD-L1 Biomarker Testing Market Size by Region, (2018-2029)
1.6.3 North America PD-L1 Biomarker Testing Market Size and Prospect (2018-2029)
1.6.4 Europe PD-L1 Biomarker Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific PD-L1 Biomarker Testing Market Size and Prospect (2018-2029)
1.6.6 South America PD-L1 Biomarker Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa PD-L1 Biomarker Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
2.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly PD-L1 Biomarker Testing Product and Solutions
2.2.4 Eli Lilly PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca PD-L1 Biomarker Testing Product and Solutions
2.3.4 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche PD-L1 Biomarker Testing Product and Solutions
2.4.4 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
2.5.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck PD-L1 Biomarker Testing Product and Solutions
2.6.4 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer PD-L1 Biomarker Testing Product and Solutions
2.7.4 Pfizer PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global PD-L1 Biomarker Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of PD-L1 Biomarker Testing by Company Revenue
3.2.2 Top 3 PD-L1 Biomarker Testing Players Market Share in 2022
3.2.3 Top 6 PD-L1 Biomarker Testing Players Market Share in 2022
3.3 PD-L1 Biomarker Testing Market: Overall Company Footprint Analysis
3.3.1 PD-L1 Biomarker Testing Market: Region Footprint
3.3.2 PD-L1 Biomarker Testing Market: Company Product Type Footprint
3.3.3 PD-L1 Biomarker Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global PD-L1 Biomarker Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global PD-L1 Biomarker Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America PD-L1 Biomarker Testing Consumption Value by Type (2018-2029)
6.2 North America PD-L1 Biomarker Testing Consumption Value by Application (2018-2029)
6.3 North America PD-L1 Biomarker Testing Market Size by Country
6.3.1 North America PD-L1 Biomarker Testing Consumption Value by Country (2018-2029)
6.3.2 United States PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
6.3.3 Canada PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe PD-L1 Biomarker Testing Consumption Value by Type (2018-2029)
7.2 Europe PD-L1 Biomarker Testing Consumption Value by Application (2018-2029)
7.3 Europe PD-L1 Biomarker Testing Market Size by Country
7.3.1 Europe PD-L1 Biomarker Testing Consumption Value by Country (2018-2029)
7.3.2 Germany PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
7.3.3 France PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
7.3.5 Russia PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
7.3.6 Italy PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2018-2029)
8.3.2 China PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8.3.3 Japan PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8.3.5 India PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
8.3.7 Australia PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America PD-L1 Biomarker Testing Consumption Value by Type (2018-2029)
9.2 South America PD-L1 Biomarker Testing Consumption Value by Application (2018-2029)
9.3 South America PD-L1 Biomarker Testing Market Size by Country
9.3.1 South America PD-L1 Biomarker Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
10.3.4 UAE PD-L1 Biomarker Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 PD-L1 Biomarker Testing Market Drivers
11.2 PD-L1 Biomarker Testing Market Restraints
11.3 PD-L1 Biomarker Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 PD-L1 Biomarker Testing Industry Chain
12.2 PD-L1 Biomarker Testing Upstream Analysis
12.3 PD-L1 Biomarker Testing Midstream Analysis
12.4 PD-L1 Biomarker Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-L1 Biomarker Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global PD-L1 Biomarker Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global PD-L1 Biomarker Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
Table 8. Agilent Technologies PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Eli Lilly Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly PD-L1 Biomarker Testing Product and Solutions
Table 13. Eli Lilly PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eli Lilly Recent Developments and Future Plans
Table 15. AstraZeneca Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca PD-L1 Biomarker Testing Product and Solutions
Table 18. AstraZeneca PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AstraZeneca Recent Developments and Future Plans
Table 20. Roche Company Information, Head Office, and Major Competitors
Table 21. Roche Major Business
Table 22. Roche PD-L1 Biomarker Testing Product and Solutions
Table 23. Roche PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Roche Recent Developments and Future Plans
Table 25. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 26. Bristol-Myers Squibb Major Business
Table 27. Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
Table 28. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bristol-Myers Squibb Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck PD-L1 Biomarker Testing Product and Solutions
Table 33. Merck PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck Recent Developments and Future Plans
Table 35. Pfizer Company Information, Head Office, and Major Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer PD-L1 Biomarker Testing Product and Solutions
Table 38. Pfizer PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Pfizer Recent Developments and Future Plans
Table 40. Global PD-L1 Biomarker Testing Revenue (USD Million) by Players (2018-2023)
Table 41. Global PD-L1 Biomarker Testing Revenue Share by Players (2018-2023)
Table 42. Breakdown of PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in PD-L1 Biomarker Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key PD-L1 Biomarker Testing Players
Table 45. PD-L1 Biomarker Testing Market: Company Product Type Footprint
Table 46. PD-L1 Biomarker Testing Market: Company Product Application Footprint
Table 47. PD-L1 Biomarker Testing New Market Entrants and Barriers to Market Entry
Table 48. PD-L1 Biomarker Testing Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global PD-L1 Biomarker Testing Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2018-2023)
Table 51. Global PD-L1 Biomarker Testing Consumption Value Forecast by Type (2024-2029)
Table 52. Global PD-L1 Biomarker Testing Consumption Value by Application (2018-2023)
Table 53. Global PD-L1 Biomarker Testing Consumption Value Forecast by Application (2024-2029)
Table 54. North America PD-L1 Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America PD-L1 Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America PD-L1 Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America PD-L1 Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America PD-L1 Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America PD-L1 Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe PD-L1 Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe PD-L1 Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe PD-L1 Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe PD-L1 Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe PD-L1 Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe PD-L1 Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America PD-L1 Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America PD-L1 Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America PD-L1 Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America PD-L1 Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America PD-L1 Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America PD-L1 Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 84. PD-L1 Biomarker Testing Raw Material
Table 85. Key Suppliers of PD-L1 Biomarker Testing Raw Materials
List of Figures
Figure 1. PD-L1 Biomarker Testing Picture
Figure 2. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2022
Figure 4. PD-L1 IHC 22C3 Assay
Figure 5. PD-L1 IHC 28-8 Assay
Figure 6. PD-L1 (SP142) Assay
Figure 7. PD-L1 (SP263) Assay
Figure 8. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. PD-L1 Biomarker Testing Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Diagnostic Center Picture
Figure 12. Others Picture
Figure 13. Global PD-L1 Biomarker Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global PD-L1 Biomarker Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market PD-L1 Biomarker Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region in 2022
Figure 18. North America PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South America PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. Global PD-L1 Biomarker Testing Revenue Share by Players in 2022
Figure 24. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players PD-L1 Biomarker Testing Market Share in 2022
Figure 26. Global Top 6 Players PD-L1 Biomarker Testing Market Share in 2022
Figure 27. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2018-2023)
Figure 28. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2024-2029)
Figure 29. Global PD-L1 Biomarker Testing Consumption Value Share by Application (2018-2023)
Figure 30. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2024-2029)
Figure 31. North America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2018-2029)
Figure 32. North America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2029)
Figure 33. North America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2018-2029)
Figure 34. United States PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. France PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Region (2018-2029)
Figure 48. China PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. India PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 54. South America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2018-2029)
Figure 55. South America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2029)
Figure 56. South America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE PD-L1 Biomarker Testing Consumption Value (2018-2029) & (USD Million)
Figure 65. PD-L1 Biomarker Testing Market Drivers
Figure 66. PD-L1 Biomarker Testing Market Restraints
Figure 67. PD-L1 Biomarker Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of PD-L1 Biomarker Testing in 2022
Figure 70. Manufacturing Process Analysis of PD-L1 Biomarker Testing
Figure 71. PD-L1 Biomarker Testing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
